# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001493152-24-035390
Filing Date
2024-09-09
Accepted
2024-09-09 07:30:14
Documents
29
Period of Report
2024-09-09
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form8-k.htm iXBRL | 8-K | 49639
2 |  | ex99-1.htm | EX-99.1 | 19173
3 |  | ex99-1_001.jpg | GRAPHIC | 514084
4 |  | ex99-1_002.jpg | GRAPHIC | 529626
5 |  | ex99-1_003.jpg | GRAPHIC | 272709
6 |  | ex99-1_004.jpg | GRAPHIC | 260571
7 |  | ex99-1_005.jpg | GRAPHIC | 164592
8 |  | ex99-1_006.jpg | GRAPHIC | 205271
9 |  | ex99-1_007.jpg | GRAPHIC | 183400
10 |  | ex99-1_008.jpg | GRAPHIC | 280926
11 |  | ex99-1_009.jpg | GRAPHIC | 216735
12 |  | ex99-1_010.jpg | GRAPHIC | 175196
13 |  | ex99-1_011.jpg | GRAPHIC | 240269
14 |  | ex99-1_012.jpg | GRAPHIC | 328470
15 |  | ex99-1_013.jpg | GRAPHIC | 306382
16 |  | ex99-1_014.jpg | GRAPHIC | 176846
| Complete submission text file | 0001493152-24-035390.txt |  | 5622948

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
17 | XBRL SCHEMA FILE | hrow-20240909.xsd | EX-101.SCH | 3944
18 | XBRL DEFINITION FILE | hrow-20240909_def.xml | EX-101.DEF | 32001
19 | XBRL LABEL FILE | hrow-20240909_lab.xml | EX-101.LAB | 38304
20 | XBRL PRESENTATION FILE | hrow-20240909_pre.xml | EX-101.PRE | 28608
31 | EXTRACTED XBRL INSTANCE DOCUMENT | form8-k_htm.xml | XML | 7996

Mailing Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215
Business Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215 615.733.4731
HARROW, INC. (Filer) CIK: 0001360214 (see all company filings)

EIN.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35814 | Film No.: 241285859
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)